Table: Oncolys Biopharma -2017 parent forecast
Jan 31 (Reuters) -
Oncolys Biopharma Inc.
PARENT- ONLY EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2017 Dec 31, 2017
LATEST PREVIOUS
FORECAST FORECAST
Sales 229 mln 200 mln
Operating loss 1.08 loss 1.40
Recurring loss 1.09 loss 1.40
Net loss 1.09 loss 1.40
EPS loss 106.23 yen loss 152.08 yen
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T
((Tokyo Headline News Desk +813 6441 1812))